THU174 Model-Based Analysis Of IGF-I Response, Dosing, And Monitoring For Once-Weekly Somapacitan In Children With GH Deficiency

Disclosure: R.J. Kildemoes: Employee; Self; Novo Nordisk. Stock Owner; Self; Novo Nordisk. Y. Kamal Lyauk: Employee; Self; Novo Nordisk. J.C. Blair: Speaker; Self; Novo Nordisk, Pfizer, Inc., Ipsen. Other; Self; Novo Nordisk. B.S. Miller: Consulting Fee; Self; Novo Nordisk, Abbvie, Endo Pharmaceutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kildemoes, Rasmus Juul, Lyauk, Yassine Kamal, Blair, Joanne C, Miller, Bradley S, Mori, Jun, Rasmussen, Michael Højby, Backeljauw, Philippe F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555744/
http://dx.doi.org/10.1210/jendso/bvad114.1425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555744/
http://dx.doi.org/10.1210/jendso/bvad114.1425

Ejemplares similares